NYSE: CMRECostamare Inc Stock
$12.33-0.27 (-2.14%)
Updated Sep 16, 2025
CMRE Price
$12.33
Fair Value Price
N/A
Market Cap
$1.62B
52 Week Low
$6.63
52 Week High
$15.96
P/E
5.2x
P/B
0.83x
P/S
0.71x
PEG
4.14x
Dividend Yield
1.87%
Revenue
$1.53B
Earnings
$304.55M
Gross Margin
46.1%
Operating Margin
27.12%
Profit Margin
18.5%
Debt to Equity
0.88
Operating Cash Flow
$543M
Beta
0.97
Next Earnings
Oct 31, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CMRE Overview
Costamare Inc. provides container ships for charter. The container ships operate primarily under multi-year time charters and therefore are not subject to the effect of seasonal variations in demand. The company was founded in 1975 and its headquarters are in Athens, Greece.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CMRE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shipping
Industry Rating
D
CMRE
Ranked#6 of 33
Ranked#6 of 33
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $31.96 | B | |
| $61.82 | B | |
| $7.14 | B |
Be the first to know about important CMRE news, forecast changes, insider trades & much more!
CMRE News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CMRE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CMRE ($12.33) is trading below its intrinsic value of $15.33, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMRE is good value based on its earnings relative to its share price (5.2x), compared to the US market average (37.55x)
P/E vs Market Valuation
CMRE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CMRE due diligence checks available for Premium users.
Valuation
CMRE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
5.2x
Industry
10.31x
Market
37.55x
CMRE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CMRE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CMRE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.83x
Industry
0.89x
CMRE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CMRE price to earnings growth (PEG)
For valuing profitable companies with growth potential
CMRE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CMRE's financial health
Profit margin
Revenue
-$5.5M
Net Income
$88.7M
Profit Margin
-1,525.9%
CMRE's Earnings (EBIT) of $415.89M... subscribe to Premium to read more.
Interest Coverage Financials
CMRE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.7B
Liabilities
$1.7B
Debt to equity
0.88
CMRE's short-term assets ($618.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CMRE's long-term liabilities ($1.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CMRE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CMRE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$147.5M
Investing
-$99.3M
Financing
-$410.7M
CMRE's operating cash flow ($543.28M)... subscribe to Premium to read more.
Debt Coverage Financials
CMRE vs Shipping Stocks
Costamare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.